These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 23466061)

  • 1. Diversity of cytogenetic and pathohistologic profiles in glioblastoma.
    Hassler M; Seidl S; Fazeny-Doerner B; Preusser M; Hainfellner J; Rössler K; Prayer D; Marosi C
    Cancer Genet Cytogenet; 2006 Apr; 166(1):46-55. PubMed ID: 16616111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
    Eoli M; Menghi F; Bruzzone MG; De Simone T; Valletta L; Pollo B; Bissola L; Silvani A; Bianchessi D; D'Incerti L; Filippini G; Broggi G; Boiardi A; Finocchiaro G
    Clin Cancer Res; 2007 May; 13(9):2606-13. PubMed ID: 17473190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide.
    Pojo M; Gonçalves CS; Xavier-Magalhães A; Oliveira AI; Gonçalves T; Correia S; Rodrigues AJ; Costa S; Pinto L; Pinto AA; Lopes JM; Reis RM; Rocha M; Sousa N; Costa BM
    Oncotarget; 2015 Apr; 6(10):7657-74. PubMed ID: 25762636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Go or grow': the key to the emergence of invasion in tumour progression?
    Hatzikirou H; Basanta D; Simon M; Schaller K; Deutsch A
    Math Med Biol; 2012 Mar; 29(1):49-65. PubMed ID: 20610469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional profiling of HOXA9-regulated genes in human glioblastoma cell models.
    Gonçalves CS; Xavier-Magalhães A; Pojo M; Oliveira AI; Correia S; Reis RM; Sousa N; Rocha M; Costa BM
    Genom Data; 2015 Sep; 5():54-8. PubMed ID: 26484224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond Genetics in Glioma Pathways: The Ever-Increasing Crosstalk between Epigenomic and Genomic Events.
    Martínez R
    J Signal Transduct; 2012; 2012():519807. PubMed ID: 22778947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chaperone protein P4HB predicts temozolomide response and prognosis in malignant glioma.
    Sun S; Kiang KM; Leung GK
    Oncol Lett; 2022 Aug; 24(2):264. PubMed ID: 35765277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis.
    Gonçalves CS; Xavier-Magalhães A; Martins EP; Pinto AA; Pires MM; Pinheiro C; Reis RM; Sousa N; Costa BM
    Mol Oncol; 2020 Jun; 14(6):1224-1241. PubMed ID: 31923345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agents.
    Szeliga M; Zgrzywa A; Obara-Michlewska M; Albrecht J
    J Neurochem; 2012 Nov; 123(3):428-36. PubMed ID: 22888977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential roles for Gfi1 in the pathogenesis and proliferation of glioma.
    Huang H; Xiang Y; Su B; Xiong W; Zhang X
    Med Hypotheses; 2013 May; 80(5):629-32. PubMed ID: 23466061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
    Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
    Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transcriptional regulation of O(6)-methylguanine-DNA methyltransferase MGMT in glioblastomas.
    Ramakrishnan V; Kushwaha D; Koay DC; Reddy H; Mao Y; Zhou L; Ng K; Zinn P; Carter B; Chen CC
    Cancer Biomark; 2011-2012; 10(3-4):185-93. PubMed ID: 22674304
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.